Gå ubegrenset med Magzter GOLD
Få ubegrenset tilgang til over 9000 magasiner, aviser og premiumhistorier for bare
Prøve GULL - Gratis
Roche moves SC against Natco over Risdiplam sale in India
Mint Bangalore
|October 15, 2025
Swiss drugmaker Roche has moved the Supreme Court, seeking to restrain Natco Pharma from selling the generic version of its lifesaving spinal muscular atrophy (SMA) drug Risdiplam in India.
Roche holds an Indian patent for Risdiplam, valid from May 2015 to May 2035.
(REUTERS)
Roche approached the apex court after the Delhi High Court division bench on 9 October refused to bar Natco Pharma from selling the generic version, upholding a March single-judge order that denied Roche an injunction.
The plea for urgent listing wasmentioned on Tuesday by Roche’scounsel beforea bench led by chief justice B.R. Gavai, which agreed to hear the matteron Thursday or Friday.
Denne historien er fra October 15, 2025-utgaven av Mint Bangalore.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Mint Bangalore
Mint Bangalore
Tech focus drives Meesho’s IPO prep
lier this month.
1 mins
November 29, 2025
Mint Bangalore
LIC’s response to voting on RIL, Adani resolutions
A Mint story on Friday reported how Life Insurance Corp. of India Ltd, or LIC, had approved or never opposed resolutions proposed before shareholders of Reliance Industries Ltd (RIL) or any Adani Group company since 1 April 2022, even as it rejected similar proposals at other large companies.
1 min
November 29, 2025
Mint Bangalore
After a year’s pause, AT-I bonds return with Canara Bank
Canara Bank on Friday raised ₹3,500 crore from an additional tier-1 (AT-I) offer, according to three people aware of the matter.
1 min
November 29, 2025
Mint Bangalore
Inside Bengaluru's quiet recycling revolution
Stories from the alleys and gullies of India
4 mins
November 29, 2025
Mint Bangalore
Speciality chemical makers are betting big on pharma
The Street is gravitating toward speciality chemical manufacturers that supply contract development and manufacturing organizations (CDMO) and active pharmaceutical ingredient (API) makers, as uncertainty looms over the chemicals sector.
1 mins
November 29, 2025
Mint Bangalore
The hero who made the movies larger
There are so many Dharmendras to love. Our tribute to the actor whose casual charm belied his larger-than-life aura
4 mins
November 29, 2025
Mint Bangalore
Art Deco feels in Indian fashion
The 100-year-old style has inspired design worldwide. Why doesn't it have a big presence in Indian fashion?
4 mins
November 29, 2025
Mint Bangalore
Indian IT slashes spending on US lobbying on H-1B visa blues
The Indian IT industry has been lowering its lobbying spends in the US in recent years, according to filings made to the US House of Representatives and accessed by Mint.
1 min
November 29, 2025
Mint Bangalore
Fiscal deficit widens on higher capex, lower tax
India’s fiscal deficit for the April-October period rose on higher capital expenditure and lower net tax revenue.
1 min
November 29, 2025
Mint Bangalore
Recreating Dharmendra's timeless style
The late movie superstar was the definition of what it means to have a strong personal style
1 min
November 29, 2025
Listen
Translate
Change font size